Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT2A receptor
Étienne Billard(McGill University), Terence E. Hébert(McGill University), Stefano Comai(University of Padua), Danilo De Gregorio(University of Campania "Luigi Vanvitelli"), Antonella Bertazzo(University of Padua), Emily Grant(Montreal Neurological Institute and Hospital), Antonio Inserra(South Australian Health and Medical Research Institute), David Chatenet(Institut National de la Recherche Scientifique), Alexandre Torbey(Institut National de la Recherche Scientifique), Gabriella Gobbi(McGill University)
Cited by 10
Related Papers
Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood
|JAMA Psychiatry|2019|911
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
|Proceedings of the National Academy of Sciences|2005|677
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
|Pharmacological Reviews|2018|386
Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype
|Nature Neuroscience|2006|373